Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Journal of Visualized Experiments : Jove|May 7, 2019
The Power of Interstimulus Interval for the Assessment of Temporal Processing in RodentsKristen A McLaurin, Landhing M Moran, Hailong Li, et al.International Journal of Molecular Sciences|August 26, 2022
Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent RatsKristen A McLaurin, Hailong Li, Charles F Mactutus, et al.Neuroimmune Pharmacology and Therapeutics|July 31, 2025
Sex-dependent modulation of behavioral allocation via ventral tegmental area-nucleus accumbens shell circuitryKristen A McLaurin, Jessica M Illenberger, Hailong Li, et al.International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|October 7, 2014
Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activationLandhing M Moran, Sylvia Fitting, Rosemarie M Booze, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 5, 2016
A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic RatKristen A McLaurin, Landhing M Moran, Hailong Li, et al.Biorxiv : the Preprint Server for Biology|February 24, 2025
SEX-DEPENDENT MODULATION OF BEHAVIORAL ALLOCATION VIA VENTRAL TEGMENTAL AREA-NUCLEUS ACCUMBENS SHELL CIRCUITRYKristen A McLaurin, Jessica M Illenberger, Hailong Li, et al.Journal of Neurovirology|May 18, 2021
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damageAdam R Denton, Charles F Mactutus, Almeera U Lateef, et al.Developmental Psychobiology|September 30, 2015
The role of sensory modality in prepulse inhibition: An ontogenetic studyLandhing M Moran, Lauren L Hord, Rosemarie M Booze, et al.Scientific Reports|May 20, 2018
HIV-1 proteins dysregulate motivational processes and dopamine circuitrySarah J Bertrand, Charles F Mactutus, Steven B Harrod, et al.Neuroimmune Pharmacology and Therapeutics|January 2, 2026
S-Equol: a novel therapeutic for HIV-1-associated gastrointestinal dysbiosisMason T Rodriguez, Sarah J Olmstead, Kristen A McLaurin, et al.Pageof 12